COMPANY
Trim-Edicine Inc.
NIH awards 12
- NIH award 5R44GM123887-04 FY2021: supplement or administrative line (under $1,000); activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein therapeutic to facilitate healing of chronic wounds source ↗
- NIH award 5R44GM123887-03 FY2020: $948,478 awarded for that fiscal year; activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein therapeutic to facilitate healing of chronic source ↗
- NIH award 2R44GM123887-02 FY2019: $898,170 awarded for that fiscal year; activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein therapeutic to facilitate healing of chronic source ↗
- NIH award 5R44DK112403-03 FY2018: $105,190 awarded for that fiscal year; activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Development of protein therapeutic for acute kidney i source ↗
- NIH award 5R44DK112403-02 FY2017: $860,143 awarded for that fiscal year; activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Development of protein therapeutic for acute kidney i source ↗
- NIH award 1R43GM123887-01A1 FY2017: $262,198 awarded for that fiscal year; activity R43 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein therapeutic to facilitate healing of chroni source ↗
- NIH award 1R44DK112403-01 FY2016: $833,693 awarded for that fiscal year; activity R44 (SBIR); PI TAN, TAO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Development of protein therapeutic for acute kidney i source ↗
- NIH award 1R43AI109892-01A1 FY2014: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI SHENG, ZELIN; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Increasing viability of lung organs for transpl source ↗
- NIH award 1R43CA171402-01A1 FY2013: $156,130 awarded for that fiscal year; activity R43 (SBIR); PI SHENG, ZELIN; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Targeting ATAP-mediated Apoptosis in Treatment source ↗
- NIH award 5R44AR060019-03 FY2013: $743,260 awarded for that fiscal year; activity R44 (SBIR); PI TAKIZAWA, NORIO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein Therapeutics for Muscular Dystrophy source ↗
- NIH award 2R44AR060019-02 FY2012: $671,260 awarded for that fiscal year; activity R44 (SBIR); PI TAKIZAWA, NORIO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein Therapeutics for Muscular Dystrophy source ↗
- NIH award 1R43AR060019-01 FY2010: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI TAKIZAWA, NORIO; recipient as written: TRIM-EDICINE, INC., Columbus, OH. Protein Therapeutics for Muscular Dystrophy source ↗